Post Discharge Circadian Rhythms Post Adenotonsillectomy

Sponsor
Baylor College of Medicine (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03217708
Collaborator
(none)
0
1
54.8
0

Study Details

Study Description

Brief Summary

The purpose of this study is to utilize non-invasive, easily measurable biomarkers (heart rate, skin temperature, sleep, and activity) in the post surgical discharge period to identify trends which correlate with improved outcome and early recovery (return to baseline activity). These are measured (captured) utilizing a wearable technology (WT) device.

Return to baseline (RTB) activity for the purpose of this study is defined primarily as step count normalization as a surrogate of activity (pre versus post operative step count), and heart rate variability normalization back to preoperative baseline. Increased heart rate variability has been studied in acute care settings as a marker of poor prognosis. Please note that return to baseline is not defined for the pediatric population in the same way as adults (which is primarily questionnaire based and not applicable in children).

Condition or Disease Intervention/Treatment Phase
  • Device: Jawbone UP4

Detailed Description

Wearable technology has tremendous advantages over current methods of assessing RTB activity in the post-discharge pediatric population after AT, which rely on quality of life (QOL) scales, caregiver and patient reports, as well as nurse phone calls and office visits. These methods are biased, time and labor intensive, disease focused, and caregiver dependent. The investigators propose to use wearable technology in order to assess RTB activity. The device has validated methodology in sleep metrics (as compared to polysomnography), heart rate and activity monitoring (optical sensor and 3 plane accelerometry), and temperature measuring (galvanic skin resistance). So far, no investigators have utilized wearable technology and biomarker (heart rate, skin temperature, activity, sleep) data in the manner proposed. RTB is a difficult to measure entity in children and the investigators have defined it using step count as a marker of activity. There are no studies or "standard" to measure quality of recovery in children.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
0 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Post Discharge Circadian Dysrhythmias, Sleep Disturbances, and Return to Baseline Activity in Children With Pre-existing Obstructive Sleep Apnea After AT (Adenotonsillectomy).
Actual Study Start Date :
Aug 21, 2017
Actual Primary Completion Date :
Mar 17, 2022
Actual Study Completion Date :
Mar 17, 2022

Arms and Interventions

Arm Intervention/Treatment
Children without OSA

Children for AT due to chronic tonsillitis without OSA.

Device: Jawbone UP4
Wrist worn wearable technology will be utilized to study HR, temperature, sleep, activity changes before and after surgery.

Children with OSA

Children with OSA for AT as determined by PSG

Device: Jawbone UP4
Wrist worn wearable technology will be utilized to study HR, temperature, sleep, activity changes before and after surgery.

Outcome Measures

Primary Outcome Measures

  1. Change in circadian rhythm [3 week]

    HR (heart rate) in OSA (obstructive sleep apnea) group v. non OSA group post AT

  2. Change in circadian rhythm [3 weeks]

    Sleep in OSA group v. non OSA group post AT. Specifically the design will capture sleep metrics (REM v. non REM, arousals, movement) in order to assess sleep quality.

  3. Change in activity [3 week]

    Activity change in OSA group v. non OSA group post AT. Due to the device being able to measure activity (specifically measured as step count as indicated in the introduction), these can be compared between groups.

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 10 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • As stated previously, OSA v. non OSA
Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Texas Childrens Hospital Houston Texas United States 77030

Sponsors and Collaborators

  • Baylor College of Medicine

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Arvind Chandrakantan, Assistant Professor of Anesthesiology and Pediatrics, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT03217708
Other Study ID Numbers:
  • H-39906
First Posted:
Jul 14, 2017
Last Update Posted:
Mar 31, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 31, 2022